David M Berman

Summary

Affiliation: National Institutes of Health
Country: USA

Publications

  1. ncbi request reprint Profiling the activity of G proteins in patient-derived tissues by rapid affinity-capture of signal transduction proteins (GRASP)
    David M Berman
    Laboratory of Pathology, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA
    Proteomics 4:812-8. 2004
  2. ncbi request reprint A functional polymorphism in RGS6 modulates the risk of bladder cancer
    David M Berman
    Laboratory of Pathology, National Cancer Institute, Bethesda, Maryland 20892, USA
    Cancer Res 64:6820-6. 2004
  3. pmc Tumor progression can occur despite the induction of very high levels of self/tumor antigen-specific CD8+ T cells in patients with melanoma
    Steven A Rosenberg
    Surgery Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA
    J Immunol 175:6169-76. 2005
  4. pmc Measuring tissue-based biomarkers by immunochromatography coupled with reverse-phase lysate microarray
    Martin J Romeo
    Laboratory of Pathology, Surgery Branch, and Biostatistics and Data Management Section, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, USA
    Clin Cancer Res 12:2463-7. 2006
  5. pmc Adoptive cell transfer therapy following non-myeloablative but lymphodepleting chemotherapy for the treatment of patients with refractory metastatic melanoma
    Mark E Dudley
    Surgery Branch, National Cancer Institute, NIH, CRC 3 3940, 10 Center Dr MSC 1201, Bethesda MD 20892 1202, USA
    J Clin Oncol 23:2346-57. 2005
  6. pmc Loss of S100 antigenicity in metastatic melanoma
    Dara L Aisner
    Laboratory of Pathology, National Cancer Institute, Bethesda, MD 20892, USA
    Hum Pathol 36:1016-9. 2005
  7. ncbi request reprint Skin reactions in a subset of patients with stage IV melanoma treated with anti-cytotoxic T-lymphocyte antigen 4 monoclonal antibody as a single agent
    Samer H Jaber
    Dermatology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD 20892 1908, USA
    Arch Dermatol 142:166-72. 2006
  8. ncbi request reprint A nonsynonymous single-nucleotide polymorphism in the PDZ-Rho guanine nucleotide exchange factor (Ser1416Gly) modulates the risk of lung cancer in Mexican Americans
    Jian Gu
    Department of Epidemiology, The University of Texas M D Anderson Cancer Center, Houston, Texas, USA
    Cancer 106:2716-24. 2006
  9. ncbi request reprint Borderline ovarian tumors: diverse contemporary viewpoints on terminology and diagnostic criteria with illustrative images
    Jeffrey D Seidman
    Department of Pathology, Washington Hospital Center, Washington DC 20010, USA
    Hum Pathol 35:918-33. 2004
  10. ncbi request reprint Molecular genetic analysis of ovarian serous cystadenomas
    Eric J Cheng
    Department of Pathology, The Johns Hopkins University, Baltimore, MD 21231, USA
    Lab Invest 84:778-84. 2004

Collaborators

Detail Information

Publications12

  1. ncbi request reprint Profiling the activity of G proteins in patient-derived tissues by rapid affinity-capture of signal transduction proteins (GRASP)
    David M Berman
    Laboratory of Pathology, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA
    Proteomics 4:812-8. 2004
    ..GRASP represents an advance in the field of proteomics as it detects protein interactions present in cells as they exist in their native tissue microenvironment...
  2. ncbi request reprint A functional polymorphism in RGS6 modulates the risk of bladder cancer
    David M Berman
    Laboratory of Pathology, National Cancer Institute, Bethesda, Maryland 20892, USA
    Cancer Res 64:6820-6. 2004
    ..These data provide the first evidence that RGS proteins may be important modulators of cancer risk and validate RGS6 as a target for further study...
  3. pmc Tumor progression can occur despite the induction of very high levels of self/tumor antigen-specific CD8+ T cells in patients with melanoma
    Steven A Rosenberg
    Surgery Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA
    J Immunol 175:6169-76. 2005
    ..Further, the induction of even high levels of antitumor T cells may be insufficient to alter tumor progression...
  4. pmc Measuring tissue-based biomarkers by immunochromatography coupled with reverse-phase lysate microarray
    Martin J Romeo
    Laboratory of Pathology, Surgery Branch, and Biostatistics and Data Management Section, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, USA
    Clin Cancer Res 12:2463-7. 2006
    ..Furthermore, RPM is currently limited by time-consuming microdissection and low amounts of evaluable protein lysates...
  5. pmc Adoptive cell transfer therapy following non-myeloablative but lymphodepleting chemotherapy for the treatment of patients with refractory metastatic melanoma
    Mark E Dudley
    Surgery Branch, National Cancer Institute, NIH, CRC 3 3940, 10 Center Dr MSC 1201, Bethesda MD 20892 1202, USA
    J Clin Oncol 23:2346-57. 2005
    ..We investigated the combination of lymphodepleting chemotherapy followed by the adoptive transfer of autologous tumor reactive lymphocytes for the treatment of patients with refractory metastatic melanoma...
  6. pmc Loss of S100 antigenicity in metastatic melanoma
    Dara L Aisner
    Laboratory of Pathology, National Cancer Institute, Bethesda, MD 20892, USA
    Hum Pathol 36:1016-9. 2005
    ..We conclude that all S100-negative melanomas could be correctly identified by negative workup for carcinoma, lymphoma, and sarcoma plus (1) GP100/MART-1 immunoreactivity and/or (2) prior documentation of melanoma...
  7. ncbi request reprint Skin reactions in a subset of patients with stage IV melanoma treated with anti-cytotoxic T-lymphocyte antigen 4 monoclonal antibody as a single agent
    Samer H Jaber
    Dermatology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD 20892 1908, USA
    Arch Dermatol 142:166-72. 2006
    ....
  8. ncbi request reprint A nonsynonymous single-nucleotide polymorphism in the PDZ-Rho guanine nucleotide exchange factor (Ser1416Gly) modulates the risk of lung cancer in Mexican Americans
    Jian Gu
    Department of Epidemiology, The University of Texas M D Anderson Cancer Center, Houston, Texas, USA
    Cancer 106:2716-24. 2006
    ..Recently, the authors reported that 3 single-nucleotide polymorphisms (SNPs) in 2 members of the RGS family were associated with significant reductions in the risk of cancer...
  9. ncbi request reprint Borderline ovarian tumors: diverse contemporary viewpoints on terminology and diagnostic criteria with illustrative images
    Jeffrey D Seidman
    Department of Pathology, Washington Hospital Center, Washington DC 20010, USA
    Hum Pathol 35:918-33. 2004
    ..For those issues where there is disagreement, the terminology and diagnostic approaches reflecting the differing views are presented...
  10. ncbi request reprint Molecular genetic analysis of ovarian serous cystadenomas
    Eric J Cheng
    Department of Pathology, The Johns Hopkins University, Baltimore, MD 21231, USA
    Lab Invest 84:778-84. 2004
    ..Accordingly, it appears that serous cystadenomas develop as a hyperplastic expansion from epithelial inclusions with a clonal/neoplastic transformation occurring in a subset of them...
  11. ncbi request reprint Lysophosphatidic acid down-regulates stress fibers and up-regulates pro-matrix metalloproteinase-2 activation in ovarian cancer cells
    Thuy Vy Do
    Department of Obstetrics and Gynecology, Feinberg School of Medicine, Northwestern University, Chicago Illinois, USA
    Mol Cancer Res 5:121-31. 2007
    ..Collectively, these results were consistent with a model in which LPA stimulates the metastatic dissemination of EOC cells by initiating loss of adhesion and metalloproteinase activation...
  12. ncbi request reprint Risk factors for the development of bronchiectasis in HIV-infected children
    David M Berman
    Division of Pediatric Infectious Disease and Special Immunology, University of Miami School of Medicine, Jackson Memorial Medical Center, Miami, Florida 33701, USA
    Pediatr Pulmonol 42:871-5. 2007
    ..3%), respectively (P-value = 0.005). HIV-1 infected children with a history of recurrent pneumonia, profound immuno-suppression (CDC immunologic category 3), and LIP appear to have a higher risk of developing bronchiectasis...